Direct Oral Anticoagulants (DOACs)

Direct Oral Anticoagulants (DOACs) are medications used to prevent blood clots in conditions like atrial fibrillation or after certain surgeries. Unlike traditional anticoagulants, which require frequent blood tests and dietary restrictions, DOACs offer a more convenient option. They work by directly inhibiting specific proteins in the blood involved in clotting, helping to reduce the risk of strokes and other complications. Common DOACs include rivaroxaban, apixaban, and dabigatran. Due to their ease of use, they have become popular among both patients and healthcare providers for managing clotting risks.